SanBio Company Limited (TYO: 4592)
Japan
· Delayed Price · Currency is JPY 764.00
+46.00 (6.41%)
Dec 27, 2024, 3:45 PM JST
SanBio Company Statistics
Total Valuation
SanBio Company has a market cap or net worth of JPY 51.75 billion. The enterprise value is 50.17 billion.
| Market Cap | 51.75B |
| Enterprise Value | 50.17B |
Important Dates
The last earnings date was Monday, December 16, 2024.
| Earnings Date | Dec 16, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SanBio Company has 68.63 million shares outstanding. The number of shares has increased by 5.87% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 68.63M |
| Shares Change (YoY) | +5.87% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 28.16% |
| Owned by Institutions (%) | -5.24% |
| Float | 48.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 83.91 |
| P/TBV Ratio | 90.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -17.22 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.80, with a Debt / Equity ratio of 0.75.
| Current Ratio | 3.80 |
| Quick Ratio | 3.17 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -377.92 |
Financial Efficiency
Return on equity (ROE) is -233.60% and return on invested capital (ROIC) is -111.68%.
| Return on Equity (ROE) | -233.60% |
| Return on Assets (ROA) | -60.04% |
| Return on Capital (ROIC) | -111.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -100.47M |
| Employee Count | 29 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.87% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +1.87% |
| 50-Day Moving Average | 931.36 |
| 200-Day Moving Average | 839.78 |
| Relative Strength Index (RSI) | 34.30 |
| Average Volume (20 Days) | 684,095 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.30B |
| Pretax Income | -2.80B |
| Net Income | -2.91B |
| EBITDA | -3.29B |
| EBIT | -3.30B |
| Earnings Per Share (EPS) | -42.82 |
Balance Sheet
The company has 2.04 billion in cash and 464.00 million in debt, giving a net cash position of 1.57 billion or 22.94 per share.
| Cash & Cash Equivalents | 2.04B |
| Total Debt | 464.00M |
| Net Cash | 1.57B |
| Net Cash Per Share | 22.94 |
| Equity (Book Value) | 616.68M |
| Book Value Per Share | 8.99 |
| Working Capital | 1.80B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SanBio Company does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.87% |
| Shareholder Yield | -5.87% |
| Earnings Yield | -5.68% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |